Slideshow
Author(s):
The new guideline section stresses that testing is the only way to accurately discriminate between the 2 viruses and advises on influenza vaccination and treatment.
The National Institutes of Health (NIH) on October 22, 2020 made updates to its COVID-19 Treatment Guidelines that provide information for clinicians in communities where influenza viruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are co-circulating.
Titled Influenza and COVID-19, the new section in the guideline discusses:
Get a top-line review in the short slideshow that follows.
Physicians can influence patient decisions on vaccines against flu, COVID-19, RSV